CIPLA VALGANCICLOVIR valganciclovir (as hydrochloride) 450 mg tablet bottle

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

valganciclovir hydrochloride, Quantity: 496.3 mg (Equivalent: valganciclovir, Qty 450 mg)

Fáanlegur frá:

Cipla Australia Pty Ltd

INN (Alþjóðlegt nafn):

Valganciclovir hydrochloride

Lyfjaform:

Tablet, film coated

Samsetning:

Excipient Ingredients: povidone; stearic acid; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000; iron oxide red

Stjórnsýsluleið:

Oral

Einingar í pakka:

60 tablets

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

CIPLA VALGANCICLOVIR is indicated for the treatment of cytomegalovirus (CMV) retinitis in adult patients with acquired immunodeficiency syndrome (AIDS).,CIPLA VALGANCICLOVIR is indicated for the prophylaxis of CMV disease in adult and paediatric solid organ transplantation (SOT) patients who are at risk.

Vörulýsing:

Visual Identification: Pink coloured, capsule shaped, biconvex film coated tablet plain on both sides; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Leyfisstaða:

Licence status A

Leyfisdagur:

2016-09-02